Interventional Radiological Management of Hepatocellular Carcinoma

Abhishek Bansal; Arvind Chaturvedi

doi:10.4103/ijmpo.ijmpo_256_19

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2020; 41(04): 484-487
DOI: 10.4103/ijmpo.ijmpo_256_19

Editorial Commentary

Interventional Radiological Management of Hepatocellular Carcinoma

Authors

Abhishek Bansal

Department of Radiology and Interventional Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
Arvind Chaturvedi

Department of Radiology and Interventional Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India

Abstract

Full Text

References

References
1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
2 Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 2019; 156: 477-910
3 Dyson J, Jaques B, Chattopadyhay D, Lochan R, Graham J, Das D. et al. Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team. J Hepatol 2014; 60: 110-7
4 Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G. et al. Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol 2006; 44: 723-31
5 Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL. et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16
6 Cheung TT, Kwok PC, Chan S, Cheung CC, Lee AS, Lee V. et al. Hong Kong consensus statements for the management of unresectable hepatocellular carcinoma. Liver Cancer 2018; 7: 40-54
7 Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J. et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: A local experience and a systematic review. World J Surg Oncol 2010; 8: 55
8 Kumar R, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Characteristics of hepatocellular carcinoma in India: A retrospective analysis of 191 cases. QJM 2008; 101: 479-85
9 Shrimal A, Prasanth M, Kulkarni AV. Interventional radiological treatment of hepatocellular carcinoma: An update. Indian J Surg 2012; 74: 91-9
10 Molla N, AlMenieir N, Simoneau E, Aljiffry M, Valenti D, Metrakos P. et al. The role of interventional radiology in the management of hepatocellular carcinoma. Curr Oncol 2014; 21: e480-92
11 Daher S, Massarwa M, Benson AA, Khoury T. Current and future treatment of hepatocellular carcinoma: An updated comprehensive review. J Clin Transl Hepatol 2018; 6: 69-78
12 Bouza C, López-Cuadrado T, Alcázar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009; 9: 31
13 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21: S192-203
14 Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M. et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 2004; 4: 782-7
15 Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W. et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-63
16 Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-2
17 European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. J Hepatol 2012; 56: 908-43
18 Song JE, Kim DY. Conventional vs. drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma. World J Hepatol 2017; 9: 808-14
19 Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol 2013; 30: 3-11
20 Lencioni R, de Baere T, Burrel M, Caridi JG, Lammer J, Malagari K. et al. Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical recommendations. Cardiovasc Intervent Radiol 2012; 35: 980-5
21 Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H. et al. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford) 2017; 19: 659-66
22 Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol 2015; 7: 2009-19
23 Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S. et al. Transarterial radioembolization for hepatocellular carcinoma: A review. J Hepatocell Carcinoma 2016; 3: 25-9
24 Gramenzi A, Golfieri R, Mosconi C, Cappelli A, Granito A, Cucchetti A. et al. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: A cohort study with propensity score analysis. Liver Int 2015; 35: 1036-47
25 Liapi E, Geschwind JF. Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma. Liver Cancer 2012; 1: 201-15
26 Meyer T, Fox R, Ma YT, Ross PJ, James MW, Sturgess R. et al. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): A randomised placebo-controlled, double-blind, phase 3 trial. Lancet Gastroenterol Hepatol 2017; 2: 565-75
27 Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC. et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: Long-term patient outcomes. Int J Radiat Oncol Biol Phys 2012; 82: 2004-11
28 Tazawa J, Maeda M, Sakai Y, Yamane M, Ohbayashi H, Kakinuma S. et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 2001; 16: 660-5